×
App Icon
The Standard e-Paper
Join Thousands Daily
★★★★ - on Play Store
Download App

NHIF members can now access enhanced prostate cancer drug

NHIF Building, Nairobi. [Jonah Onyango, Standard]

Prostate cancer patients covered by the National Hospital Insurance Fund (NHIF) can now access a new drug that enhances treatment.

The drug, Abiraterone Acetate, from Janssen Kenya, is used for treating advanced prostate cancer and will be available to NHIF members within their benefits package after an agreement between NHIF and Janssen Kenya.

Premium Article

Get Full Access for Ksh299/Week.

Uncover the stories others won't tell. Subscribe now for exclusive access.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902